John Kramer

3PUBLICATIONS
4CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 07, 2025
Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosis.

Shiv Saidha, John Kramer, Brandon Brown

|Apr 12, 2024
New onset lymphopenia in patients with relapsing multiple sclerosis switching from long-standing dimethyl fumarate treatment to diroximel fumarate: A case series.

Megan Schneider, John Kramer, Aimee Banks

|Oct 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis.

John Kramer, Ralf Linker, David Paling

Pageof 1